A CRDMO is a contract research, development, and manufacturing organization in life sciences. These firms support drug discovery, process development, testing, and production for other companies, often handling intellectual property, experimental data, formulas, and regulated records. Because they sit in the supply chain for pharmaceutical and biotech work, a CRDMO can be a high-value cyber target.
In cyber attacks, a CRDMO may be targeted for ransomware, extortion, or credential theft because disruption can stop research or manufacturing and create pressure on customers as well as the provider. Attackers may also seek confidential project data to steal trade secrets or threaten public leaks. Defenders should treat CRDMOs as sensitive third parties: enforce strong identity controls, segment production and research systems, monitor for unauthorized access, and test backups and recovery plans. Public victim listings can name a CRDMO before the technical facts are confirmed, so verification matters.